Company Filing History:
1 out of 1,309 
1 out of 11 Years Active: 2012
Title: Riccardo Zanaletti: Innovator in Nicotinic Acetylcholine Receptor Modulation
Introduction
Riccardo Zanaletti is a notable inventor based in Colle Val d'Elsa, Italy. He has made significant contributions to the field of pharmacology, particularly in the modulation of nicotinic acetylcholine receptors. His work has implications for treating various neurological and psychiatric disorders.
Latest Patents
Zanaletti holds a patent for "Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof." This invention provides compounds that can modulate alpha7 nicotinic acetylcholine receptors, which are crucial in treating a variety of disorders, diseases, and conditions. The compounds can influence neurological, psychiatric, and inflammatory systems, showcasing their potential therapeutic applications.
Career Highlights
Throughout his career, Zanaletti has worked with prominent companies in the pharmaceutical industry. He has been associated with Wyeth and Siena Biotech S.p.a., where he has contributed to research and development efforts in innovative therapeutic solutions.
Collaborations
Zanaletti has collaborated with talented individuals in his field, including Chiara Ghiron and Arianna Nencini. These collaborations have likely enriched his research and contributed to the advancement of his inventions.
Conclusion
Riccardo Zanaletti's work in modulating nicotinic acetylcholine receptors represents a significant advancement in therapeutic innovation. His contributions continue to impact the field of pharmacology and offer hope for treating complex disorders.